1. Home
  2. XGN vs STXS Comparison

XGN vs STXS Comparison

Compare XGN & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XGN
  • STXS
  • Stock Information
  • Founded
  • XGN 2002
  • STXS 1990
  • Country
  • XGN United States
  • STXS United States
  • Employees
  • XGN N/A
  • STXS N/A
  • Industry
  • XGN Medical Specialities
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • XGN Health Care
  • STXS Health Care
  • Exchange
  • XGN Nasdaq
  • STXS Nasdaq
  • Market Cap
  • XGN 138.3M
  • STXS 151.3M
  • IPO Year
  • XGN 2019
  • STXS 2004
  • Fundamental
  • Price
  • XGN $10.10
  • STXS $2.89
  • Analyst Decision
  • XGN Strong Buy
  • STXS
  • Analyst Count
  • XGN 4
  • STXS 0
  • Target Price
  • XGN $11.75
  • STXS N/A
  • AVG Volume (30 Days)
  • XGN 374.8K
  • STXS 879.8K
  • Earning Date
  • XGN 07-29-2025
  • STXS 08-07-2025
  • Dividend Yield
  • XGN N/A
  • STXS N/A
  • EPS Growth
  • XGN N/A
  • STXS N/A
  • EPS
  • XGN N/A
  • STXS N/A
  • Revenue
  • XGN $58,862,000.00
  • STXS $31,806,000.00
  • Revenue This Year
  • XGN $19.68
  • STXS $29.03
  • Revenue Next Year
  • XGN $13.68
  • STXS $44.05
  • P/E Ratio
  • XGN N/A
  • STXS N/A
  • Revenue Growth
  • XGN 3.89
  • STXS 33.94
  • 52 Week Low
  • XGN $2.38
  • STXS $1.54
  • 52 Week High
  • XGN $10.29
  • STXS $3.05
  • Technical
  • Relative Strength Index (RSI)
  • XGN 77.40
  • STXS 66.30
  • Support Level
  • XGN $9.39
  • STXS $2.73
  • Resistance Level
  • XGN $9.90
  • STXS $3.05
  • Average True Range (ATR)
  • XGN 0.44
  • STXS 0.16
  • MACD
  • XGN 0.03
  • STXS 0.03
  • Stochastic Oscillator
  • XGN 88.52
  • STXS 81.61

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: